MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,335,000 | -64.2% | 1,076,803 | -11.2% | 0.05% | -65.2% |
| Q1 2017 | $3,734,000 | -41.8% | 1,212,478 | -22.9% | 0.13% | -43.1% |
| Q4 2016 | $6,418,000 | -37.3% | 1,572,978 | -2.4% | 0.23% | -37.6% |
| Q3 2016 | $10,234,000 | +17.6% | 1,611,678 | -0.2% | 0.37% | +17.4% |
| Q2 2016 | $8,703,000 | -11.7% | 1,614,678 | +37.2% | 0.32% | -10.2% |
| Q1 2016 | $9,851,000 | +27.1% | 1,176,978 | +12.0% | 0.35% | +40.6% |
| Q4 2015 | $7,751,000 | -13.4% | 1,051,178 | 0.0% | 0.25% | -13.7% |
| Q3 2015 | $8,946,000 | -31.2% | 1,051,178 | 0.0% | 0.29% | -20.9% |
| Q2 2015 | $12,998,000 | +225.0% | 1,051,178 | +212.2% | 0.37% | +217.2% |
| Q1 2015 | $4,000,000 | +8.3% | 336,700 | +3.1% | 0.12% | +5.5% |
| Q4 2014 | $3,692,000 | +543.2% | 326,700 | +399.5% | 0.11% | +511.1% |
| Q3 2014 | $574,000 | +42.1% | 65,400 | +18.1% | 0.02% | +50.0% |
| Q2 2014 | $404,000 | +192.8% | 55,400 | +102.2% | 0.01% | +140.0% |
| Q1 2014 | $138,000 | -5.5% | 27,400 | 0.0% | 0.01% | -28.6% |
| Q4 2013 | $146,000 | – | 27,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|